RiboX Therapeutics
- Biotech or pharma, therapeutic R&D
RiboX Therapeutics is a global biotechnology company developing fully engineered Circular RNA therapeutics and is the first and only clinical-stage Circular RNA company. RiboX has established proprietary plug-and-play circular RNA, ionizable lipids, and active targeting LNP platforms. Its therapeutic areas include Radiation-induced Xerostomia, in-vivo CAR-T, Duchenne Muscular Dystrophy, Ornithine Transcarbamylase Deficiency, Bone Regeneration, Vaccines, Dermatology and Medical Aesthetics.